Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report)’s share price fell 3.3% during mid-day trading on Monday . The stock traded as low as $54.07 and last traded at $54.07. 120,819 shares were traded during trading, a decline of 92% from the average session volume of 1,495,266 shares. The stock had previously closed at $55.91. […]
Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price Up 2 3% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.73) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.73), Briefing.com reports. The business had revenue of $146.38 million during the quarter, compared to the consensus estimate of $143.34 million. Apellis Pharmaceuticals had a negative return […]
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price objective cut by Citigroup from $70.00 to $67.00 in a research note published on Friday, Benzinga reports. They currently have a buy rating on the stock. Other analysts have also recently issued reports about the company. Bank of America upgraded Apellis Pharmaceuticals from a neutral rating […]
Apellis Pharmaceuticals (NASDAQ:APLS) PT Lowered to $56 00 etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.